Chang Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chang Lv has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Chunyu Lv
Graduate School of Zunyi Medical University, Zunyi 563003, China
1 shared publication - Jinhai Mu
Graduate School of Dalian University, Dalian 116044, China
1 shared publication - Li-Bin Zhan
Department of Traditional Chinese Medicine, the Second Affiliated Hospital, Dalian Medical University, Dalian 116023, China
1 shared publication - Robbie Ali
Windber Hospital Inc, Windber Medical Center, Windber, PA 15963, USA
1 shared publication - Siyao Li
Graduate School of Zunyi Medical University, Zunyi 563003, China
1 shared publication - Xiaoguang Lu
Department of Emergency Medicine, Zhongshan Hospital, Dalian University, Dalian, China
1 shared publication
Latest Publications
- Open Access
- 1 March 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 80
Dai Huang Fu Zi Tang could ameliorate intestinal injury in a rat model of hemorrhagic shock by regulating intestinal blood flow and intestinal expression of p-VASP and ZO-1
Dai Huang Fu Zi Tang (DHFZT), an oriental herbal formula, has long been used clinically in treatment of intestinal obstruction, acute pancreatitis, cholecystalgia and chronic diarrhea for thousands of years. Recent studies have demonstrated that DHFZT can reduce intestinal pathological injury and the concentration of enterogenous endotoxin in an animal model. But the underlying mechanism has not been fully elucidated.
- 1 March 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 80
Open AccessDai Huang Fu Zi Tang could ameliorate intestinal injury in a rat model of hemorrhagic shock by regulating intestinal blood flow and intestinal expression of p-VASP and ZO-1
Dai Huang Fu Zi Tang (DHFZT), an oriental herbal formula, has long been used clinically in treatment of intestinal obstruction, acute pancreatitis, cholecystalgia and chronic diarrhea for thousands of years. Recent studies have demonstrated that DHFZT can reduce intestinal pathological injury and the concentration of enterogenous endotoxin in an animal model. But the underlying mechanism has not been fully elucidated.